$DNTH 4 SEC Filings

Filed On	Filing
18 Sep 2026	Form 4: Carr Edward, CHIEF ACCOUNTING OFFICER Received 20,000 shares by exercise or conversion ($358K) · Sold 20,000 shares ($2.03M)
03 Sep 2026	Form 4: Randhawa Simrat, EVP, Head of R&D Received 23,124 shares by exercise or conversion ($477K) · Sold 23,124 shares ($2.46M)
19 Aug 2026	Form 4: Read Simon, Director Received 2,778 shares by exercise or conversion ($51K) · Sold 2,778 shares ($327K)
14 Aug 2026	Form 4: Veness Adam M, SVP, General Counsel and Sec. Received 15,000 shares by exercise or conversion ($273K)
11 Aug 2026	Form 4: McGeorge Anne, Director Received 7,750 shares by exercise or conversion ($97K) · Sold 7,750 shares ($845K)
11 Aug 2026	Form 4: Read Simon, Director Received 2,777 shares by exercise or conversion ($51K) · Sold 2,777 shares ($304K)
11 Aug 2026	Form 4: Veness Adam M, SVP, General Counsel and Sec. Received 3,833 shares by exercise or conversion ($68.5K) · Sold 3,833 shares ($424K) · Received 16,167 shares by exercise or conversion ($289K) · 1 more
07 Aug 2026	Form 4: Garcia Marino, Director Received 166,000 shares by exercise or conversion ($1.4M) · Sold 166,000 shares ($17.9M)
13 Jul 2026	Form 4: Savitz Ryan, EVP, CFO & CBO Received 31,249 shares by exercise or conversion ($680K) · Sold 31,249 shares ($3.16M)
18 Jun 2026	Form 4: Veness Adam M, SVP, General Counsel and Sec. Received 30,000 shares by exercise or conversion ($536K) · Sold 30,000 shares ($2.42M)
02 Jun 2026	Form 4: Randhawa Simrat, EVP, Head of R&D Received 26,530 shares by exercise or conversion ($500K) · Sold 26,530 shares ($2.4M)
22 May 2026	Form 4: Read Simon, Director Granted 6,090 Stock Option (Right to Buy)
22 May 2026	Form 4: Romano Steven J., Director Granted 6,090 Stock Option (Right to Buy)
22 May 2026	Form 4: McGeorge Anne, Director Granted 6,090 Stock Option (Right to Buy)
22 May 2026	Form 4: Lawton Alison Frances, Director Granted 6,090 Stock Option (Right to Buy)
22 May 2026	Form 4: Kango Sujay, Director Granted 6,090 Stock Option (Right to Buy)
22 May 2026	Form 4: Violin Jonathan, Director Granted 6,090 Stock Option (Right to Buy)
22 May 2026	Form 4: Soteropoulos Paula, Director Granted 6,090 Stock Option (Right to Buy)
11 May 2026	Form 4: Soteropoulos Paula, Director Received 599 shares by exercise or conversion ($5.06K) · Sold 599 shares ($51.2K)
10 Apr 2026	Form 4: Savitz Ryan, EVP, CFO & CBO Received 8,224 shares by exercise or conversion ($147K) · Sold 8,224 shares ($739K)

Comments